Stay updated on Safety of PBCAR20A in NHL/CLL Clinical Trial
Sign up to get notified when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.

Latest updates to the Safety of PBCAR20A in NHL/CLL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA 403 Forbidden error page is now shown instead of the study details, indicating an access issue rather than new or updated study information.SummaryDifference20%

- Check33 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0. This update reflects an internal version bump rather than changes to the study content or user-facing information.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a small update to the study record rather than a substantive change to the study details.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5. This is a metadata/version update.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now lists Revision: v3.6.4, signaling an administrative update to the study page. The previous Revision: v3.6.3 label appears to have been removed.SummaryDifference0.0%

Stay in the know with updates to Safety of PBCAR20A in NHL/CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PBCAR20A in NHL/CLL Clinical Trial page.